Testing how a natural brain chemical affects irregular heartbeat in rats
Part of Heart & circulation clinical trials.
This study looks at how a natural substance in the body (N/OFQ) and certain antibodies might cause irregular heartbeats. It is being tested in rats, not people, so it's early research to understand the heart's response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 2 diabetes (according to Chinese medical guidelines).
- You must have coronary heart disease (diagnosed by a doctor).
- You cannot have heart failure, a tumor, an immune system disease, or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the heart uses energy fuel in people with heart failure, including those with type 2 diabetes. It may help researchers understand what’s going on inside the heart and how it could be treated in the future.
This study measures immune cells from your blood to find markers (biomarkers) that may explain or predict diabetic cardiomyopathy, a type of heart condition linked to diabetes. You may benefit mainly by being closely monitored and contributing to research that could improve future diagnosis or risk tracking.
This study looks at how cells talk to each other in people who have both diabetes and heart failure. It may help doctors understand these conditions better.
This study looks at medical records of people who had a heart attack or heart failure and also have diabetes or prediabetes. Researchers will use artificial intelligence to find patterns that might help doctors treat these conditions better in the future.
This trial tests a heart-focused prevention approach to lower the risk of cardiac (heart) events in adults with type 2 diabetes. It may help by targeting early stress on the heart measured with a specific blood test.
This study looks at whether certain diabetes medicines, called SGLT2 inhibitors and GLP-1 receptor agonists, can help protect the heart in people with type 2 diabetes. It may help you understand if these treatments are a good option for your heart health.
Hear when a new Acute Myocardial Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.